Cantourage Group SE, a medical cannabis company, produces and distributes medical cannabis preparations and cannabis-based pharmaceuticals in Europe and internationally. The company offers cannabis dried flowers, extracts, dronabinol/tetrahydrocannabinol (THC), and cannabidiol (CBD) products. It exports its products to other European countries. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.
Frequently asked questions
What sector does CANTOURAGE GROUP SE O.N. (HIGH) operate in?
CANTOURAGE GROUP SE O.N. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is CANTOURAGE GROUP SE O.N. (HIGH) current stock price?
As of the latest data, CANTOURAGE GROUP SE O.N. stock price is €5.14, with a previous close of €5.08. CANTOURAGE GROUP SE O.N. gained €0.06 in the last trading session, representing a 1.18% increase.
What is CANTOURAGE GROUP SE O.N. (HIGH) current market capitalization?
CANTOURAGE GROUP SE O.N. market cap is approximately 61.04 million.
What is CANTOURAGE GROUP SE O.N. (HIGH) Earnings Per Share (EPS)?
The trailing EPS is -€0.33, and the forward EPS is €0.32.
Does CANTOURAGE GROUP SE O.N. (HIGH) pay dividends?
No. CANTOURAGE GROUP SE O.N. does not pay a dividend.
What is CANTOURAGE GROUP SE O.N. (HIGH) beta (volatility) score?
CANTOURAGE GROUP SE O.N. has a beta of -0.073, indicating lower volatility than the overall market.